EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Vir Biotechnology (VIR) Posts 80.98% Year-To-Date Growth
10 Best Small-Cap Biotech Stocks According to Hedge Funds
Vir Biotechnology (VIR) Is Up 19.1% After Astellas Cancer Pact Closes With $315M Inflows
Can Vir Biotechnology (VIR)'s Masked T-Cell Technology Crack the Hardest-to-Treat Prostate Cancer?
Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year High - Here's Why - Stock Observer
Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?
Vir Biotechnology (VIR) Valuation After Astellas Partnership And New VIR 5500 Trial Milestone
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer | Morningstar
Phase 1 trial designed to assess the safety, pharmacokinetic
Brokerages Set Vir Biotechnology, Inc. (NASDAQ:VIR) PT at $20.44
Should Vir's CMO Exit and Astellas Funding Boost Reshape How Investors View Its R&D Strategy (VIR)?
Vir Biotechnology (VIR) Leading with Its BiTEs Therapy
Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages
Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares
Is Vir Biotechnology's (VIR) Insider Selling After Its Capital Raise Reframing the Investment Narrative?
Vir Biotechnology (NASDAQ:VIR) Director Sells $199,540.00 in Stock
Nordea Investment Management AB Sells 104,835 Shares of Vir Biotechnology, Inc. $VIR - Markets Daily
VirBiotechnology news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
